Clinical Trial Update: The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sequential hormone therapy followed by IBI311 therapy in active moderate to severe thyroid-associated ophthalmopathy, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• IBI311

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Thyroid Associated Ophthalmopathies | Phase 4 | Status: RECRUITING